Elspeth M Beauchamp

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Dendritic Cells

Immune Response

Cell Cycle Arrest

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, Ricardo E Perez, G Sohae Yang, Frank D Eckerdt, Elspeth M Beauchamp, Ye Hou, Qixuan Wang, Rona Singer Weinberg, Eleanor N Fish, Feng Yue, Ronald Hoffman, Leonidas C Platanias
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer research communications 3 (5) (2023)
Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, Ricardo E Perez, G Sohae Yang, Frank D Eckerdt, Elspeth M Beauchamp, Ye Hou, Qixuan Wang, Rona Singer Weinberg, Eleanor N Fish, Feng Yue, Ronald Hoffman, Leonidas C Platanias
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer research communications 3 (5) (2023)
Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, Ricardo E Perez, G Sohae Yang, Frank D Eckerdt, Elspeth M Beauchamp, Ye Hou, Qixuan Wang, Rona Singer Weinberg, Eleanor N Fish, Feng Yue, Ronald Hoffman, Leonidas C Platanias
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer research communications 3 (5) (2023)
Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, Ricardo E Perez, G Sohae Yang, Frank D Eckerdt, Elspeth M Beauchamp, Ye Hou, Qixuan Wang, Rona Singer Weinberg, Eleanor N Fish, Feng Yue, Ronald Hoffman, Leonidas C Platanias
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer research communications 3 (5) (2023)
Diana Saleiro, Ewa M Kosciuczuk, Mariafausta Fischietti, Ricardo E Perez, G Sohae Yang, Frank D Eckerdt, Elspeth M Beauchamp, Ye Hou, Qixuan Wang, Rona Singer Weinberg, Eleanor N Fish, Feng Yue, Ronald Hoffman, Leonidas C Platanias
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells. Cancer research communications 3 (5) (2023)